Expert insights reveal how 3D cellular models are revolutionising preclinical testing and clinical translation.

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to ...

The fresh energy brought by the revitalized research attention offers an opportunity to more closely integrate novel drug discovery, residue monitoring, and ...

Organ-on-a-chip systems offer a more accurate, ethical, and scalable alternative to animal testing in drug discovery and ...

PORTLAND, IN, UNITED STATES, July 3, 2025 /EINPresswire.com/ -- According to the report, the global animal model market was valued at $1.9 billion in 2022 and is estimated to reach $3.6 billion by ...

UB scientists Ram Samudrala, PhD, and Zackary M. Falls, PhD, talk about the new platform to make drug discovery faster and less expensive while also being safe and effective.

Recursion Pharmaceuticals RXRX is redefining the traditional model of drug discovery by harnessing the power of artificial intelligence (AI) through its proprietary RecursionOS platform, developed in ...

Advances in computational biology, bioinformatics, artificial intelligence (AI), and high-performance computing have dramatically accelerated the ...

Optibrium, a leading developer of software and AI solutions for molecular design, today announced its partnership with ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

Here we use cryogenic electron microscopy to determine the structure of TbAQP2 from Trypanosoma brucei, bound to either the substrate glycerol or to the sleeping sickness drugs, pentamidine or ...